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We present an experimental and computational pipeline for the generation of kinetic models of
metabolism, and demonstrate its application to glycolysis in Saccharomyces cerevisiae. Starting from
an approximate mathematical model, we employ a ‘‘cycle of knowledge’’ strategy, identifying the
steps with most control over ﬂux. Kinetic parameters of the individual isoenzymes within these
steps are measured experimentally under a standardised set of conditions. Experimental strategies
are applied to establish a set of in vivo concentrations for isoenzymes and metabolites. The data are
integrated into a mathematical model that is used to predict a new set of metabolite concentrations
and reevaluate the control properties of the system. This bottom-up modelling study reveals that
control over the metabolic network most directly involved in yeast glycolysis is more widely distrib-
uted than previously thought.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A major goal of systems biology is the development of
mathematical models of biological phenomena that predict their
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nation of their mechanisms, and that have predictive power as to
the effects of changes in their parameters [1–4]. For cellular phe-
nomena, this requires models that represent the action of multiple
enzymes as contributors to the behaviour observed. Fortunately,
this area of systems biology is built on the strong foundations of
enzymology dating from the work of Michaelis and Menten [5],
with their model of the dependency of the rate of enzymatic reac-
tions on the concentration of their substrates. Their famous rate
law, and similar ones for reversible reactions and reactions with
multiple substrates and products, are the building blocks for ki-
netic models of metabolism.
So far, the majority of mathematical models of biochemical
pathways have been developed based on data collected from
different sources [6]. The enzyme kinetic data used in such models
have usually been measured at each enzyme’s optimal pH; how-
ever the optimal pH of each enzyme in a pathway is normally dif-
ferent and the physiological pH and other conditions would not
match the optimal conditions for each enzyme [7]. Due to the
shortage of comprehensive experimental datasets acquired under
speciﬁc experimental conditions, this approach may result in a dis-
torted view, i.e., one not fully representative of the system under
study. Any unknown parameters of the model are estimated
through the ﬁnding of a best ﬁt to an available set of experimental
data. However, there is potentially an enormous number of param-
eter values providing the same degree of ﬁtting (whatever the ﬁt-
ting metric), and hence the ﬁtted model may not be a good
representation of the real system and may thereby fail to predict
its behaviour under different conditions. From a computational
perspective this issue has been addressed through sampling
approaches [8]. From an experimental perspective the optimal
experimental strategy must aim to deliver as comprehensive an
information content as possible under a uniﬁed set of experimental
conditions that should mimic the intracellular environment as
much as possible.
In kinetic modelling, the potential for alternative isoenzymes
catalysing each metabolic reaction step is generally overlooked.
For prokaryotic systems this is likely to be relatively unimportant
since a given activity is more commonly controlled by a single
gene/protein. However, in eukaryotes, there are often multiple
gene/protein isoforms that may act separately and with different
activities under different environmental conditions, or may occur
in different cellular compartments. For example, Gu et al. [9] have
estimated that there are 530, 674, and 1219 duplicate protein
families in Saccharomyces cerevisiae, Drosophila melanogaster and
Caenorhabditis elegans, respectively. These isoenzymes may play
an especially important role in S. cerevisiae whose metabolism
has evolved through whole-genome duplication and subsequent
gene loss [10,11] or divergence [12]. Representation of the distinct
isoenzyme activities has not been addressed in any signiﬁcant ki-
netic models of metabolic processes to date. Thus, enzymes with
identical or similar activities have mostly been integrated together
(as in the model of glycolysis of Teusink et al. [13]) and measured
as a lumped activity without distinguishing and appreciating the
individual characteristics of each isoform. In practice, we can ex-
pect differential activities of individual isoenzymes based on
changes in the environmental conditions or growth cycle.
In this paper, we introduce a novel strategy that addresses the
above sources of heterogeneity by producing complete sets of
experimentally-derived data using the same parental strain of S.
cerevisiae and identical growth conditions. Furthermore, we char-
acterise individual isoforms of enzymes involved in the biochemis-
try of central carbon metabolism and their differential roles.
As with any system, parameters are distinguished from
variables. In a given metabolic network, the parameters are the
concentrations of enzymes and their kinetic properties, while thevariables are represented by ﬂuxes and concentrations [14]. One
strategy therefore isolates the individual components of a system,
measures their properties (parameters) in vitro, and uses knowl-
edge of these to reconstruct the network as a mathematical model.
This model can then be (and is) used to describe the time-depen-
dent and steady-state concentrations and ﬂuxes in the network.
Separate measurements of those variables allow one to test the
precision of the model. The model can also serve to highlight
potential sources of error in experimental measurements that
can then be re-evaluated (e.g., Ref. [15]).
Our strategy and workﬂow [2] for producing and testing
systems biology models is summarised in Fig. 1. We have chosen
to construct mathematical models of distinct and important areas
of metabolism (in terms of the amount of ﬂux carried) and have
used S. cerevisiae as a model system to develop and validate our
approach. We stress a number of features of this approach:
1 The external conditions for the biological system (the cell
culture) are well deﬁned, and these act as a source for the
metabolites that are taken up by the system.
2 A topological description of the network is then constructed,
in which all metabolic reactions are deﬁned and associated
to all isoenzymes known to catalyse the reaction. This pro-
cess is performed by extracting a sub-network from larger,
genome-scale metabolic networks, or by compiling litera-
ture data [16–20].
3 A kinetic model is built upon the metabolic map deﬁned in
point 2. Rate laws and parameter values are either taken
from pre-existing models or estimated from published data.
4 The model is evaluated through software packages such as
COPASI [21] and used to predict ﬂuxes and metabolite con-
centrations at steady-state.
5 The control properties of the system are evaluated computa-
tionally and the reaction step exerting the major control
over the system ﬂuxes is identiﬁed.
6 The kinetic properties of the most controlling reaction step
are experimentally measured. More particularly, the turn-
over number (kcat), concentration and afﬁnity constants of
each of the corresponding isoenzymes are measured and
their value is used to reﬁne the model.
7 Points 3–5 are repeated until all the reactions in the model
have been fully characterised.
8 Once this has been performed for all the elements in the net-
work, the predicted steady-state values of the ﬂuxes and
metabolite concentrations are compared with their corre-
sponding experimental measurements.
9 The model’s parameters are then adjusted as appropriate to
minimise the mismatch between predicted and measured
quantities.
10 All of the relevant data and models are deposited in suitable
databases.
As with any new strategy for approaching biochemical (or
other) problems, it is appropriate to calibrate or validate it by
applying it to a well-understood system. Glycolysis represents an
excellent test-case [13,22–24]. It is a universal metabolic pathway
conserved across all three domains of life (Archaea, Bacteria and
Eukarya, though with some variations) consuming glucose to pro-
duce free energy in the form of ATP and reducing equivalents in the
form of NADH, and precursors that are used in other cellular met-
abolic processes. Glycolysis is also of applied interest for the pur-
poses of biomass production in the baking industry [25], as a
catalyst for a variety of biotransformations [26–28] and in ethanol
production [29–30].
S. cerevisiae is also a particularly suitable organism in which to
perform such a study from a number of other perspectives: it is
Fig. 1. The strategy for bottom-up systems biology used. The meaning of the numbers is described in the text.
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tions of continuous culture in which its metabolism can adopt a
steady state [31–33]. These conditions allow multiple proteome
and metabolome samples to be acquired, and ensure a high repro-
ducibility of measurements and hence ﬁdelity of the ﬁnal results.
This article describes the overall strategy set out above and
illustrates the accuracy of systems biology modelling that is
currently achievable with such a strategy. This is also the ﬁrst time
that the individual contributions by different isoenzymes have
been accounted for in such detail, whether in a model or
experimentally.
2. Materials and methods
2.1. Enzyme production and puriﬁcation
Enzymes were expressed in S. cerevisiae strains that contain
either an overexpression plasmid with the open reading frame of
interest, which was under control of the GAL1 inducible promoter
and in fusion to a multiple tag at the C-terminus (Yeast ORF Collec-
tion, [34]) and N-terminus (Yeast GST-Tagged Collection [35]) or a
chromosomally integrated gene with a tag fusion (TAP collection
[36]). All collections are available from Open Biosystems (http://
www.thermoscientiﬁcbio.com/openbiosystems/). The expressions
and puriﬁcation of proteins was performed as described by Malys
et al. [37–38]. The success of each step of puriﬁcation for each
protein was assessed by analysing samples from the intermediate
and ﬁnal protein preparations using SDS–PAGE. The amount and
concentration of the puriﬁed enzyme was determined using
QuantiPro™ BCA Assay Kit (Sigma–Aldrich) according to the
manufacturer’s recommendations. The quality of the enzyme
preparation was further assessed using a 2100 Bioanalyzer (Agilent
Technologies).
Although the overexpression of proteins with tags provides sig-
niﬁcant advantages by increasing throughput and protein recovery
from the cell extract, it also brings some limitations related to the
function and structure of enzymes. The position of the tag on the
protein may interfere with its folding, multimeric complex
formation, or functionality. Therefore, in some cases, as for
example, enolase 2 (ENO2, EC 4.2.1.11) an alternative construct
with an N-terminal tag had to be used. The use of Yeast MORF
and Yeast GST-Tagged collections [34–35] in combination allows
the puriﬁcation of 80% of all S. cerevisiae proteins.
Applying a standardised approach of using a single yeast
expression collection did not allow the reconstitution of fully
active phosphofructokinase (EC 2.7.1.11) from individual Pfk1
and Pfk2 subunits. Therefore, in the second round of the
experimental cycle, PFK1 and PFK2 were co-expressed and their
protein products co-puriﬁed as a heterooctamer from the YeastTAP-Tagged collection. The activity of this complex was signiﬁ-
cantly higher than that of each isoenzyme puriﬁed alone.
2.2. Enzyme kinetic assays
To determine the kinetic parameters for individual enzymatic
reactions, spectrophotometric assays were performed for the gly-
colytic isoenzymes measuring the consumption or production of
NADH or NADPH by using one or more coupling reactions when
needed. All assays were carried out in medium-throughput mea-
surements with a BMG Labtech NOVOstar plate reader (automated
ﬂuorescence/FP/absorbance reader, Offenburg, Germany) in 384-
well format plates with a 60 ll reaction volume [39]. All assays
were performed in a standardised reaction buffer at 30 C and were
automated so that all reagents in the reaction buffer (including any
coupling enzymes) are in 45 ll, the enzyme (to be assayed) in 5 ll
and the substrate in 10 ll volumes. For each individual enzyme,
the forward and the reverse reaction were assayed whenever pos-
sible. Assays for each individual enzyme were either developed or
modiﬁed from previously published methodology to be compatible
with the conditions of the assay reactions (e.g. pH compatibility or
unavailability of commercial substrates).
All assays were coupled with enzyme(s) in which NAD(P) or
NAD(P)H is a product or substrate so that its formation or con-
sumption could be followed spectrophotometrically at 340 nm
using an extinction coefﬁcient of 6.62 mM1 cm1, unless the reac-
tion of a particular enzyme consumes or produces NADH or NADPH
in which case no coupling enzymes were used. Some assays were
modiﬁed by altering the concentration of coupling enzymes or
other reagents to ensure that the rate measured is the rate of the
reaction of interest (fully rate limiting). This is a critical step that
needs special care to be taken when using coupling enzymes in as-
says [40].
All measurements are based on at least duplicate determination
of the reaction rates at each substrate concentration. Control
experiments were run in parallel to check and correct for any back-
ground activity. For each isoenzyme, the initial rates at various
substrate concentrations were determined and the data obtained
were analyzed by the KineticsWizard [41], ﬁtting to Michaelis–
Menten kinetics:
v ¼ E kcatS=ðKm þ SÞ:
Not all enzymes were found to exhibit these kinetics. As re-
ported previously [42], triose phosphate isomerase (TPI1, EC
5.3.1.1) showed substrate inhibition in the direction of dihydroxy-
acetone phosphate production and was analysed using COPASI [21]
according to the following rate law:
V ¼ E kcatS=ðKm þ Sð1þ ðS=KiÞ4ÞÞ:
Table 1
Sequence of models generated through the cycles of experiment and modelling. At
each iteration, the uncharacterised reaction with the highest control over glucose
uptake was then replaced with our experimental data or literature data (see text for
details). Each version of the model is available from the BioModels database [60]. For
example, the ﬁnal model may be accessed at http://identiﬁers.org/biomodels.db/
MODEL1303260018. The models are also available from the JWS Online [61], where
they can be simulated online at http://jjj.mib.ac.uk/database/smallbone.
Iteration Reaction BioModels id JWS Online id
0 MODEL1303260000 Smallbone0
1 HXT MODEL1303260001 Smallbone1
2 HXK MODEL1303260002 Smallbone2
3 ATPase MODEL1303260003 Smallbone3
4 Glycerol_branch MODEL1303260004 Smallbone4
5 PFK MODEL1303260005 Smallbone5
6 Glycogen_branch MODEL1303260006 Smallbone6
7 Succinate_branch MODEL1303260007 Smallbone7
8 PDC MODEL1303260008 Smallbone8
9 TDH MODEL1303260009 Smallbone9
10 FBA MODEL1303260010 Smallbone10
11 PGI MODEL1303260011 Smallbone11
12 ENO MODEL1303260012 Smallbone12
13 PGK MODEL1303260013 Smallbone13
14 ADH MODEL1303260014 Smallbone14
15 GPM MODEL1303260015 Smallbone15
16 PYK MODEL1303260016 Smallbone16
17 TPI MODEL1303260017 Smallbone17
18 MODEL1303260018 Smallbone18
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Continuous cultures of S. cerevisiae strain Y23925 (a heterozy-
gous deletion derivative of the diploid BY4743: MATa/MATa;
his3D1/his3D1; ho::KanMX4/HO; leu2D0/leu2D0; LYS2/lys2D0;
met15D0/MET15; ura3D0/ura3D0) were established in a turbido-
stat-like approach in which the biomass was monitored by
measuring the electrical capacitance of the culture [43–46]. A feed-
back loop was applied to regulate the addition of growth medium
such that the biomass was maintained at 75% of the maximum
achieved biomass yield for that medium, where a steady state was
obtained (cf. [47]). The growth of the cultures was thus performed
without nutrient limitation and atlmax. Samples for quantiﬁcation
of both protein levels and intracellular metabolite concentrations
were collected from these continuous cultures as described below.
2.4. Proteomics
S. cerevisiae cells from 50 ml cultures were harvested by centri-
fugation for 5 min at 4000 g, and the cells mechanically disrupted
using a mini bead-beater (Biospec Products Inc., Bartlesville, USA;
http://www.biospec.com/) yielding the cellular cytoplasmic solu-
ble fraction for analysis. The latter was combined with known
amounts of the recombinant labelled QconCAT protein (containing
diagnostic peptides for the glycolytic enzymes [48]), and co-
digested to completion with trypsin. The resulting peptides were
diluted and resolved over a linear incrementing solvent gradient
by LC-MS using a nanoACQUITY chromatograph (Waters MS Tech-
nologies) coupled to an LTQ-Orbitrap XL (ThermoFisher Scientiﬁc).
Automated data analysis and subsequent calculations were carried
out using the QconCAT PrideWizard [49].
2.5. Metabolomics
For metabolomics, a quenching method was applied [50] which
sampled 10 ml of culture solution into 40 ml of a 60:40 methanol/
water solution stored at a temperature of 47 C [51]. Immediate
separation of cells was performed by applying centrifugation
(4000 g for 5 min) followed by removal of the quenching solution.
Bothwere stored at80 C prior to extraction or analysis. The intra-
cellular metabolite pool was extracted into 1250 ll of an 80:20
water/methanol solution with cell wall disruption provided by
eight freeze–thaw cycles to ensure full metabolite recovery. Sam-
ples were analysed using two analytical platforms. Fructose-1,6-
bisphosphate was quantiﬁed applying UPLC-MS (Waters Acquity
UPLC coupled to a ThermoFisher hybrid electrospray LTQ-Orbitrap
mass spectrometer (ThermoFisher Scientiﬁc, http://www.thermo-
ﬁsher.com/)) and the standard addition method for accurate quan-
tiﬁcation. Other metabolites were quantiﬁed applying GC–MS
(Agilent 6890 Gas Chromatograph coupled to a Leco Pegasus III
electron impact-time-of-ﬂight mass spectrometer (Leco, http://
www.leco.com/)) and the external calibration method for accurate
quantiﬁcation. The concentrations determined in the extracted
samples were reported as the number of molecules per cell.
The gas chromatographic separation of 2-phosphoglycerate and
3-phosphoglycerate is technically demanding and was not
achieved during this study. Therefore, the combined concentration
of both metabolites was reported rather than separate concentra-
tions for each metabolite.
2.6. Modelling
An existing model of yeast glycolysis [23] was modiﬁed so that
any ﬁxed (‘clamped’) ﬂuxes in that model were redeﬁned as
ﬁrst-order in their reactants. Where possible, initial metabolite
concentrations were updated according to in-house values;otherwise recent literature data for respiro-fermentative, non-
starved cells were used [24].
At each of 17 iterations, ﬂux control coefﬁcients [52–53] were
calculated using COPASI [21]. Where possible, the uncharacterised
reaction with the highest control over glucose uptake was then re-
placed with kinetic and proteomic data for each isoenzyme; other-
wise literature data were used (Table 1). HXT parameters were
taken from van Eunen et al. [24] (iteration 1); a saturative generic
ATPase rate law (representing the collective of all ATP consuming
processes) was taken from Teusink et al. (1998) [54] (iteration
3); the glycerol branch was replaced with the two-reaction model
of Cronwright et al. [55] (iteration 4); the glycogen and trehalose
branches were replaced with the ﬁve-reaction model of Smallbone
et al. [56] (iteration 6); acetate and succinate branches were taken
from van Eunen et al., 2012 (iteration 7); TPI function and param-
eters were taken from Mendes et al. [42], though these were mea-
sured in-house (iteration 17). We also modiﬁed the kinetics of PFK
to take account of its thermodynamic reversibility. Subsequent ﬁt-
ting was performed in COPASI.
All models are provided in standard Systems Biology Markup
Language format (SBML level 2 version 4; [57]) embedded with
principled and computer-readable annotations [17,58–59]. The
models are available from the BioModels database [60] and in
the JWS Online [61] , with the accession numbers given in Table 1.
2.7. Informatics infrastructure
The production of this model was supported by the development
of an informatics infrastructure to aid with capture and analysis of
experimental data. The toolset includes support for enzyme kinetics
[41], quantitative proteomics [49], and quantitative metabolomics
data [62–63]. Furthermore, workﬂows have been generated to auto-
mate the generation and parameterisation of kineticmodels [64–66].
3. Results and discussion
3.1. A standardised pipeline from network to kinetic model
In order to describe a biological system quantitatively, the
characteristics of all its components need to be established. Where
Table 2
Enzyme kinetics parameters determined in this project and contrasted with those of
[23].
Reaction Isoenzyme Parameter Value SEM (%) Ref. [23] Unit
ADH Adh1p kcat 176 1.3 s1
ADH Adh1p Kacald 0.462 5.3 1.11 mM
ADH Adh5p kcat 0 0 s1
ENO Eno1p kcat 7.6 1.9 s1
ENO Eno1p Kp2g 0.043 10 0.04 mM
ENO Eno2p kcat 19.9 s1
ENO Eno2p Kp2g 0.104 0.04 mM
FBA Fba1p kcat 4.14 1.5 s1
FBA Fba1p Kf16bp 0.451 5.3 0.3 mM
GPM Gpm1p kcat 400 s1
GPM Gpm1p Kp2g 1.41 0.08 mM
HXK Glk1p kcat 0.0721 s1
HXK Glk1p Kglc 0.0106 0.08 mM
HXK Glk1p Katp 0.865 0.15 mM
HXK Hxk1p kcat 10.2 s1
HXK Hxk1p Kglc 0.15 0.08 mM
HXK Hxk1p Katp 0.293 0.15 mM
HXK Hxk2p kcat 63.1 s1
HXK Hxk2p Kglc 0.2 0.08 mM
HXK Hxk2p Katp 0.195 0.15 mM
PDC Pdc1p kcat 12.1 3.5 s1
PDC Pdc1p Kpyr 8.5 10 4.33 mM
PDC Pdc5p kcat 10.3 2.1 s1
PDC Pdc5p Kpyr 7.08 5.7 4.33 mM
PDC Pdc6p kcat 9.21 s1
PDC Pdc6p Kpyr 2.92 4.33 mM
PFK Pfk1p:Pfk2p kcat 210 1.8 s1
PGI Pgi1p kcat 487 3.7 s1
PGI Pgi1p Kg6p 1.03 19 1.4 mM
PGI Pgi1p Kgf6p 0.307 6.8 0.3 mM
PGK Pgk1p kcat 58.6 s1
PGK Pgk1p Kp3g 4.58 0.53 mM
PGK Pgk1p Katp 1.99 0.3 mM
PGK Pgk1p nHadp 2
PYK Cdc19p kcat 20.1 2.9 s1
PYK Cdc19p Kpep 0.281 12 0.14 mM
PYK Cdc19p Kadp 0.243 13 0.53 mM
PYK Pyk2p kcat 0 0 s1
TDH Tdh1p kcat 19.1 1.5 s1
TDH Tdh1p Kgap 0.495 7.5 0.21 mM
TDH Tdh2p kcat 8.63 s1
TDH Tdh2p Kgap 0.77 0.21 mM
TDH Tdh3p kcat 18.2 1.8 s1
TDH Tdh3p Kgap 0.423 9.2 0.21 mM
TDH Tdh3p Kbpg 0.909 0.0098 mM
TPI Tpi1p kcat 564 1.5 s1
TPI Tpi1p Kdhap 6.45 5 mM
TPI Tpi1p Kgap 5.25 12 mM
TPI Tpi1p Kigap 35.1 3.1 mM
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measurements, even when done at different times, are performed
under identical conditions. Therefore, a controlled turbidostat
culture of S. cerevisiae strain YDL227C was grown under strictly de-
ﬁned conditions as described in Section 2, from which cell extracts
were prepared for quantifying protein and metabolite concentra-
tions. This pipeline approach was driven by the aim of using robust
and standardised experimental strategies that can easily be trans-
ferred to the characterisation of other biochemical networks. It in-
volved three distinct experimental platforms: enzyme kinetics,
quantitative metabolomics and quantitative proteomics.
In order to characterise the kinetics of isoenzymes, proteins
were expressed and puriﬁed from commercially available yeast
strain collections. Kinetic constants for these enzymes were deter-
mined as described in Materials and Methods, leading to the set of
parameters given in Table 2. The same table also compares these
with some previously published values, although those measure-
ments were taken from a different strain and at a different pH
and under a variety of other conditions.
To establish the absolute quantities of these individual isoen-
zymes in the cell, the complete protein content was extracted from
turbidostatic yeast cultures and quantiﬁed using the QconCAT ap-
proach, according to methods described previously [48,67] and in
Section 2. These concentrations are listed in Table 3.
The complete metabolite contents were extracted from the
quenched yeast cells of the same turbidostat culture and quantita-
tively measured by Ultra Performance Liquid Chromatography
(UPLC-MS [68]) and Gas Chromatography-Mass Spectrometry
(GC–MS [69]) using standard solutions of known concentration
as described in Section 2. A summary of the metabolite concentra-
tions so determined is shown in Table 4.
From a modelling perspective, the enzyme kinetic constants
and protein concentrations represent the parameters of the sys-
tem, and the metabolite concentrations represent the variables.
Combining the protein concentration data with those for the en-
zyme kinetic parameters, together with the measured steady state
metabolite levels, allows a mathematical model of yeast glycolysis
to be produced for this system, which is provided in standard SBML
[57]. A major difference in the reactions of our model when com-
pared to previous efforts in modelling metabolism (such as
[13,23]) is that isoenzymes are represented explicitly. In addition,
the enzyme kinetic parameters have been measured under stan-
dard conditions designed to mimic to a greater or lesser extent
the intracellular environment.
3.2. The cycle of knowledge is crucial for systems biology
Scientiﬁc advance may be seen as an iterative cycle linking
knowledge and ideas to observations and data [2,70–72]. Deduc-
tive reasoning uses background knowledge to construct (by un-
stated means) a hypothesis that is tested experimentally to
produce observations. By contrast, inductive (or abductive) reason-
ing is purely data-driven, generating more general (or speciﬁc)
hypotheses, rather than starting with them. Because of the high
dimensionality of typical data, computer-intensive methods are re-
quired to turn the data into knowledge.
This inductive–deductive ‘‘cycle of knowledge’’ is crucial for
systems biology: predictive mathematical models are used to
interpret, organise and integrate the range of available experimen-
tal data. The models produce hypotheses about the underlying
complex system dynamics, which are tested experimentally. The
models are then more closely validated and updated, continuing
the cycle.
Many turns of the cycle of knowledge were required to produce
this model. An existing model [23] was found not to predict our
measured metabolite levels adequately (Table 4). Thus at eachiteration, the most important reaction to characterise was identi-
ﬁed through its control over glucose uptake. This ‘most important’
reaction was then characterised experimentally, or through litera-
ture data.
For some iterations, the addition of experimental data led to a
signiﬁcant decrease in both ﬁt to our data and ﬂux through the
pathway. This was because the limiting rate (V) of these reactions
– a function of both protein concentration and turnover number –
was now too low (i.e. was lower than the estimated in vivo ﬂux).
By contrast, using all expression data simultaneously provides sub-
stantial constraints in which non-systematic noise cancels out
effectively [73]. In vitro and in vivo enzymatic activities may differ
for a number of reasons such as missing or unknown effectors, cel-
lular crowding or channelling. However, they may also differ due
to inactivation of the enzyme in the puriﬁcation or assay methods,
or by the presence of the puriﬁcation tag at the N- or C-terminus.
By applying alternative puriﬁcation and assay techniques to isoen-
zymes with low activity, new data were collected, allowing the
model to be reﬁned and improving its consistency with the
Table 3
Protein concentrations measured by QconCat, expressed as protein molecules per cell.
For comparison the data determined in [36] is also displayed.
Reaction Isoenzyme Uniprot id Molecules/cell SEM (%) Ref. [36]
ADH Adh1p P00330 494000 1.1 0
ADH Adh5p P38113 12800 8.1 1310
ENO Eno1p P00924 2070000 0.9 76700
ENO Eno2p P00925 5950000 0.7 2610
FBA Fba1p P14540 4030000 1020000
GPM Gpm1p P00950 2200000 0.6 172000
HXK Glk1p P17709 136000 5.5 21100
HXK Hxk1p P04806 50500 1.1 40800
HXK Hxk2p P04807 185000 0.6 114000
PDC Pdc1p P06169 3220000 0.8 8970
PDC Pdc5p P16467 37200 19.1 471000
PDC Pdc6p P26263 19700 1.7 1520
PFK Pfk1p P16861 141000 0.7 89800
PFK Pfk2p P16862 118000 2.8 90200
PGI Pgi1p P12709 416000 0.6 91600
PGK Pgk1p P00560 776000 1.5 314000
PYK Cdc19p P00549 6170000 1.3 291000
PYK Pyk2p P52489 18300 11.4 2130
TDH Tdh1p P00360 1060000 1.2 120000
TDH Tdh2p P00358 0 121000
TDH Tdh3p P00359 12700000 0.9 169000
TPI Tpi1p P00942 886000 0.8 207000
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carried out.
For phosphofructokinase a kcat value of 3 s1 was ﬁrst deter-
mined, which was well below what should be expected to match
the actual glycolytic ﬂux. However this is because the a and b sub-
units (products of different genes, PFK1 and PFK2) were puriﬁed
and assayed in isolation. A subsequent assay combined the a and
b subunits, that had been puriﬁed separately, in equimolar
amounts, but this still produced a low kcat value. Finally the two
subunits were co-expressed, co-puriﬁed and then assayed, result-
ing in a kcat value of 200 s1.
The reaction catalysed by the enolases was also deﬁcient in to-
tal capacity relative to the observed physiological ﬂux: the kcat of
Eno1p was 0.8 s1 and Eno2p was inactive. Since these enzymes
had been previously puriﬁed and stored at 70 C, the new exper-
iment assayed them immediately after puriﬁcation. In this case
Eno1p had a kcat of 8 s1 but Eno2p was still inactive, and the activ-
ity of Eno1p alone was not enough to explain the ﬂux. A hypothesis
was formulated that the tag in the C-terminus of Eno2p (which is
left on in the MORPH strain proteins) could be interfering with
its active site. Published evidence for the role of the C-terminus
of enolase in enzyme activity and in binding Mg2+ were found
[74–75]. Thus a new construct was obtained for ENO2 with a tag
in the N-terminus, it was expressed, puriﬁed and assayed fresh,Table 4
Measured and predicted metabolite concentrations. Experimental values determined as des
volume of 5 ﬂ (see main text). Predictions were calculated with the ﬁnal model (iteration
ID Name ChEBI id Molecules/cel
DHAP Dihydroxyacetone phosphate 16108 3500
F16bP Fructose 1,6-bisphosphate 28013 13800
F6P Fructose 6-phosphate 16084 709
G3P Glycerol 3-phosphate 15978 825
G6P Glucose 6-phosphate 17665 2330
GAP Glyceraldehyde 3-phosphate 29052 951
GLC Glucose 4167 18900
PEP Phosphoenol-pyruvate 18021 1840
PYR Pyruvate 15361 6350
P2G Glycerate 17835 1620
P3G Phosphates 17794resulting in a kcat of 20 s1, which is more than twice as active as
Eno1p.
The calculated limiting rate of the reaction catalysed by the
pyruvate decarboxylases, EC 4.1.1.1, was also below the physiolog-
ical ﬂux. The kcat values determined were: Pdc1p 3 s1, Pdc5p 2 s1,
and Pdc6p was inactive. These enzymes had been stored at 70 C
following puriﬁcation. We re-puriﬁed them and performed the as-
say immediately after the puriﬁcation. This time, the kcat values for
the three enzymes were all 10 s1, which leads to the conclusion
that the storage had caused loss of activity.
The enzyme concentration of fructose bisphosphate aldolase
(Fba1p, EC 4.1.2.13) was updated from 5  105–4  106 molecules
per cell, after reinterpretation of the proteomics data. Lysine acet-
ylation occurred on an internal lysine residue of an analyte peptide
from Fba1p. This led to division of the analyte signal between the
modiﬁed and unmodiﬁed forms, present in our data, and resulted
in an underestimation of the total analyte signal [48]. Thus the
inclusion of post-translational modiﬁcations as well as isozyme
data can lead to more precise estimations of relevant kinetic
parameters.
It is important to note that experimental problems such as
those described above only came to light upon modelling of the en-
tire system. Since this project included iterative modelling and
experimental components, replicate experiments could be carried
out when needed. This contrasts with previous modelling ap-
proaches that typically relied upon third-party experimental data.
It also highlights that the iterative and integrative modelling ap-
proach followed here has an important role in quality control for
the experimental data, which would not be applicable to dedicated
experimental studies that do not contain a modelling element.
In Fig. 2, we present the change in the ﬁt betweenmodel predic-
tions and measured metabolite concentrations through each itera-
tive characterisation. While an improvement in ﬁt between the
initial model and that fed with our parameter values is seen, there
is little change in ﬁt or ﬂux after ﬁve iterations. As such, it is vital
for model predictivity only to characterise those reactions with the
highest control under standard conditions; for reactions with low-
er control, other sources may be used.
3.3. Effective cytoplasmic volume is an important parameter
Whilst many parameters were measured under standardised
conditions, some were nonetheless estimated from the literature.
The relative contribution of each unmeasured parameter to the
quality of ﬁt to data may be ranked using sensitivity analysis
(see e.g., Ref. [76]). We deﬁned a number of ﬁtting criteria: sufﬁ-
cient closeness of predicted to observed metabolite concentrations,
no drop in ﬂux into glycolysis, and an energy charge of at least 0.8
[77]. If we were unable to satisfy these criteria by ﬁtting only thecribed in Methods. Concentrations were calculated relative to an effective cytoplasmic
18 in Table 1). Data from [23] is presented for comparison.
l (103) SEM (%) Concentration (mM)
Observed Predicted Ref. [23]
18.9 1.162 1.584 1.004
20.2 4.583 2.780 6.221
14.8 0.235 0.325 0.625
24.3 0.274 0.226 0.150
9.7 0.774 1.213 2.675
26.9 0.316 0.067 0.045
4.6 6.277 0.635 0.098
23.5 0.611 0.477 0.063
16.6 2.109 3.329 1.815
17.7 0.538 0.613 1.013
Fig. 2. Improvement in ﬁt between model predictions and data as more reactions
are characterised. The ﬁlled circles denote the ﬁt as determined by normalised root
mean square difference between the measured and experimental metabolite
concentrations. Also shown is the glucose uptake rate (open circles). Both ﬁt and
ﬂux are rescaled to take value unity for the initial model.
Table 5
Flux-control coefﬁcients on the glucose input ﬂux, for the initial and ﬁnal models
(iterations 0 and 18 in Table 1).
Reaction Flux-control coefﬁcients
Model 0 Model 18
HXT 0.844 1.467
HXK 0.201 1.995
ATPase 0.076 3.303
PFK 0.045 0.356
Glycerol_branch 0.017
Glycogen_branch 0.009
Succinate_branch 0.008
TDH 0.007 0.118
ADH 0.006 0.359
Trehalose_branch 0.006
FBA 0.005 0.102
PGI 0.005 0.023
ENO 0.003 0.016
PGK 0.000 0.172
PYK 0.000 0.063
GPM 0.000 0.044
PDC 0.000 0.001
TPI 0.000 0.008
AK 0.000 0.000
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continued the cycle until complete.
The most important parameter was found to be the cytoplasmic
volume, whose role is to convert metabolite and protein copy num-
ber to molar concentration (the units in which the Michaelis–Men-
ten parameters are measured). Given estimates of cell volume of
40 ﬂ [78–79], of which around 50% is cytoplasm [80], we initially
estimated the cytoplasm to be 20 ﬂ. However, following ﬁtting,
we found that a volume of 5 ﬂ provided a much better ﬁt to our
data. This could be explained by macromolecular crowding [81],
which has the effect that the space available for water and dis-
solved molecules is much smaller than the total space, and so
the effective volume is lower. It is also important to realise that
our model represents a bulk average [82–83], so the volume should
reﬂect the average volume of cells. Actively growing cultures are
dominated by new cells recently formed by budding that have
not undergone division – these cells are smaller than those that
have already divided. Further, older cells have large vacuoles that
occupy most of the cellular space and their cytoplasmic volume
is considerably smaller than the total cellular volume [84].
The other two changes in parameter values required were both
related to bulked reactions: the ATPase rate was increased (V from
1.1 mM s1 to 5.3 mM s1) and the succinate branch was turned off
(k from 0.005 s1 to 0).
3.4. Is 3-phosphoglycerate a substrate for enolase 1?
The assays performed for phosphoglycerate mutase (GPM, EC
5.4.2.1) in the direction of 3-phosphoglycerate (P3G) to 2-phos-
phoglycerate (P2G) revealed an interaction between the substrate
P3G and the coupling enzymes system (speciﬁcally the enolase).
This made it difﬁcult to determine the kinetic properties of GPM
for the forward reaction, and hence only the kinetics for the reverse
reaction could be determined.
In studying this interaction, it was found that P3G acts as a sub-
strate for Eno1p (kcat = 5.07 s1 ± 2.9% and Km = 0.617 mM ± 10.2%),
producing phophenolpyruvate (PEP). Multiple batches from differ-
ent sources were tested and 31P NMR spectra of the P3G material
showed no evidence for the presence of P2G, hence this observa-
tion is not due to P2G contamination. There is some evidence
[85] that ENO and GPM form a metabolic channel [86]; since ourmodel assumes no channelling, this was not incorporated, but is
noted here as a discovery of interest.
3.5. Separating kinetic parameters from protein expression levels
reveals individuality of isoenzymes
In this work, we constructed a model based on three data
sources: metabolomics, proteomics and enzyme kinetics. In con-
trast to earlier work, we separated the limiting rates into two
terms representing (the product of) the enzyme level and its max-
imal turnover number: Vmax = [E]kcat. This is important because the
in vivo limiting rate is near impossible to determine. Speciﬁcally, it
is not possible to deconvolve the activity of different isoenzymes
from cell-free extracts measurements. The strategy we followed
is to determine separately [E] (by quantitative proteomics) and kcat
(using enzyme kinetics). Here the default assumption is that the
kcat of enzymes is not changed by the processes of protein puriﬁca-
tion; since we purify proteins that have tags in their C-terminus,
we also assume that the kcat (and other kinetic parameters) are
not changed by the presence of the tag. The latter condition is more
likely to be violated in some cases, so we checked for this. Indeed,
we have found that Eno2p activity was affected by C-terminus tags
(see above).
The beneﬁts of this separation are twofold. First, it allows one to
investigate the effects of the different isoenzymes within the sys-
tem. For example glucokinase (Glk1p, EC 2.7.1.2) has lower activity
than the two hexokinases (Hxk1p and Hxk2p, EC 2.7.1.1); however
it also has a higher afﬁnity for its substrate glucose (see Table 2),
allowing it to operate effectively at low substrate concentrations.
Secondly, the kinetic characteristics of enzymes remain fairly
constant under different growth conditions. Rather, cells respond
to cues through changing enzyme levels, validating the assump-
tions stated above. As such, knowledge of enzyme levels under dif-
ferent physiological conditions may be combined with a speciﬁc
set of kinetic data to create a suite of mathematical models of a
system.
3.6. Metabolic control analysis
In Table 5, we present the ﬂux-control coefﬁcients (FCC [52]) for
the initial and ﬁnal models. For the initial model, the three main
controllers of glucose uptake appeared to be glucose transport,
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trol in the ﬁnal model, though through decomposition we ﬁnd that
it is speciﬁcally Hxk2p (FCC 1.91), rather than Hxk1p (FCC 0.08) or
Glk1p (FCC 0.001) that exerts most of the ﬂux control. Overall, we
found in the original model that 95% of the total control is exerted
by these three reactions plus PFK. By contrast, in the ﬁnal model,
control is distributed more widely over the whole system, with
95% of control distributed over ten reactions. This represents a sub-
stantial change in the picture as our understanding was reﬁned.
This is also different from distributions in other organisms; for
example, in Trypanosoma brucei, control over glycolytic ﬂux was
found to be almost uniquely determined by the glucose transporter
[87]. These results are also in agreement with the view of Kacser
and Burns [88] that the control of metabolism is, in general, and
necessarily, widely distributed.4. Conclusion
For over a decade, modern systems biology has been seen as a
crucial strategy and methodology for biological research. It pays
particular attention to the way in which molecules interact inside
cells in a quantitative way. Within systems biology there are two
fundamentally distinct approaches, one uses data from large-scale
measurements (transcriptomics, etc.) to reverse engineer models
directly from those data; the other approach is based on combining
enzyme kinetic data to build mechanistic biochemical network
models. The latter approach, sometimes referred to as ‘‘bottom-
up’’, is a descendent of the work of Michaelis and Menten, and at
one level uses essentially the same methodology to assess the
properties of each of the component enzymes in the system. It
has thus been common to re-use, in systems biology models, the
enzyme kinetic parameters previously estimated in enzymology
studies (e.g., Ref. [13]). The present work improves on this practice
by recognising that those enzymology studies were carried out un-
der different conditions for each enzyme, while in cells the actual
conditions are (at least, nominally) common to all enzymes of
the pathway residing in a given compartment. Here, all enzymes
– and importantly all isoenzymes – were assayed in standard con-
ditions, such that the resulting model is self-consistent and physi-
ologically relevant. The approach taken here followed the cycle of
knowledge approach [2,70–72] as several iterations of experiments
and modelling were performed. The ﬁnal model reveals that the
control of the pathway is considerably more distributed than was
thought in the past based on previous models, and is in agreement
with both experimental evidence and theoretical insights [88]. This
study provides a clear example of how bottom-up systems biology,
based on the solid foundations laid out 100 years ago by Michaelis
and Menten [5], is useful in discovering and understanding new
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